[1]
M. Foroughipour and S. Gazeran, “Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial”, Curr J Neurol, vol. 18, no. 4, pp. 154-158, Aug. 2019.